Chen Hongming
Known title: CHIEF SCIENTIFIC OFFICERCIK: 0001710697
Associated companies
Transaction History
| KALA | ▼ Sell | Open Market | 21,051 | $38K | 10/27/2021 | View on chart |
| KALA | ▼ Sell | Open Market | 9,449 | $17K | 10/26/2021 | View on chart |
| KALA | ▼ Sell | Open Market | 21,051 | $38K | 10/27/2021 | View on chart |
| KALA | ▼ Sell | Open Market | 9,449 | $17K | 10/26/2021 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
KALA Bio Signs LOI to Acquire Telehealth Platform
KALA Bio shares surged 57% after hours following the announcement of a non-binding letter of intent to acquire a nationwide telehealth platform. The target company has generated approximately $48 million in sales since inception. Additionally, the company signed a separate agreement to resell genetic testing products through a U.S. DNA testing platform.
KALA Bio Signs LOI to Acquire Telehealth Platform. KALA Bio shares surged 57% after hours following the announcement of a non-binding letter of intent to acquire a nationwide telehealth platform. The target company has generated approximately $48 million in sales since inception. Additionally, the company signed a separate agreement to resell genetic testing products through a U.S. DNA testing platform.